VG Life Sciences Inc.
VGLS
$0.00
$0.000.00%
| 09/30/2015 | 06/30/2015 | 03/31/2015 | 12/31/2014 | 09/30/2014 | |
|---|---|---|---|---|---|
| Net Income | 4.68% | 30.01% | 45.91% | 86.21% | 31.37% |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | -60.35% | -36.34% | -12.78% | -36.49% | 1,216.38% |
| Total Other Non-Cash Items | 6.29% | -19.42% | -28.53% | -75.66% | -7.48% |
| Change in Net Operating Assets | 203.06% | -37.94% | -72.75% | -529.93% | -139.70% |
| Cash from Operations | 89.69% | 23.08% | 77.24% | 24.53% | -35.07% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -82.56% | 22.64% | -0.94% | -69.14% | 76.75% |
| Total Debt Repaid | -302.08% | -1,313.04% | 10.86% | 75.23% | 81.89% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -86.33% | 9.68% | 1.00% | -68.71% | 93.32% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -11.43% | 77.81% | 99.31% | -102.85% | 122.44% |
